An uncontrolled study reported that GH treatment for up to 3 years increased growth rates in short children with nephropathic cystinosis compared with baseline, with superior growth responses observed in patients with early CKD (stage 1–3) compared with those with advanced CKD and on dialysis50. Here, GH1 is linked to nephropathic infantile cystinosis.